GLP-1 Market Set to Reach USD 133.92 Billion by 2034 with a CAGR of 10.9%

GLP-1 Market

The GLP-1 Market report by Polaris Market Research offers an in-depth comprehension of the rapidly evolving sector. It covers all the key market aspects, including market share, size, trends, and recent developments. In addition, an assessment of the top regions, key segments, and competitive landscape has been provided.

The report analyzes the market to register a CAGR of 10.9% during 2025-2034. The market was valued at USD 47.74 billion in 2024 and is projected to grow to USD 133.92 billion by 2034.

Request For a Sample with An Exclusive Look at the Latest Trends and Upcoming Advancements:
https://www.polarismarketresearch.com/industry-analysis/glp-1-market/request-for-sample

Market Introduction

GLP-1, or Glucagon-Like Peptide-1, is a naturally occurring hormone produced in the gut. It plays a crucial role in the regulation of appetite, blood sugar levels, and digestion. GLP-1 is released in response to food intake and enhances the secretion of insulin from the pancreas, while simultaneously suppressing the release of glucagon, a hormone that increases blood sugar levels. GLP-1 also slows gastric emptying, which helps prolong the feeling of fullness and contributes to reduced food intake. GLP-1 has become a key target in the treatment of type 2 diabetes and obesity owing to its multifaceted role in glucose regulation and appetite control.

Market Dynamics

• Rising Prevalence of Type 2 Diabetes Globally: The growing prevalence of type 2 diabetes globally is a major GLP-1 market driver. GLP-1 therapies play a central role in enhancing glycemic control and lowering cardiovascular risk. There is increased demand for effective treatment options, as type 2 diabetes becomes increasingly common in both developed and developing regions.
• Increasing Rates of Obesity and Related Metabolic Disorders: GLP-1 receptors have shown effectiveness in promoting weight loss and enhancing metabolic parameters. Obesity is a major risk factor for type 2 diabetes, cardiovascular diseases, and other comorbidities. This has led to an increased need for therapeutic solutions that manage multiple conditions at the same time.

Need More Information? Inquire more about this report before purchase:
https://www.polarismarketresearch.com/industry-analysis/glp-1-market/inquire-before-buying

Market Key Players

The market has the presence of both established players and new entrants. These players are leveraging strategic developments and product innovation to garner a larger market share. A few of the major market participants are:

• AstraZeneca
• Boehringer Ingelheim
• D&D Pharmatech
• Eli Lilly
• Hanmi Pharmaceutical
• Novo Nordisk
• Pfizer
• Roche
• Sanofi
• Tonghua Dongbao Pharmaceutical

Segmental Insights

Polaris Market Research has segmented the market report on the basis of route of administration, type of molecule, active compound used, type of GLP-1 agonist drug, and target indication:

GLP-1 Market, Route of Administration Outlook
• Oral
• Parenteral

GLP-1 Market, Active Compound Used Outlook
• Dulaglutide
• Liraglutide
• Orforglipron
• Retatrutide
• Semaglutide
• Survodutide
• Tirzepatide
• Other Active Compounds

GLP-1 Market, Type of GLP-1 Agonist Drugs Outlook
• Long-acting GLP-1 Agonist
• Short-acting GLP-1 Agonist

GLP-1 Market, Type of Molecule Outlook
• Biologics
• Small Molecules

GLP-1 Market, Target Indication Outlook
• Alzheimer's Disease
• Non-Alcoholic Steatohepatitis
• Obesity
• Sleep Apnea
• Type 2 Diabetes

Browse Full Report:
https://www.polarismarketresearch.com/industry-analysis/glp-1-market

Regional Overview

By region, the report offers market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America led the global GLP-1 market in 2024. The regional market dominance is primarily attributed to the high prevalence of diseases and the presence of advanced healthcare infrastructure. In addition, the early adoption of novel therapies contributes to the region's leading market position.
Asia Pacific is anticipated to witness the fastest growth from 2025 to 2034. This is due to the rapid rise in lifestyle-related diseases and increased access to healthcare. The growing awareness about diabetes and obesity management is contributing to the robust market growth in the region.

Top Trending Reports of Polaris Market Research:

Latin America Fabry Disease Treatment Market
https://www.polarismarketresearch.com/industry-analysis/latin-america-fabry-disease-treatment-market
MENA Fabry Disease Treatment Market
https://www.polarismarketresearch.com/industry-analysis/middle-east-north-africa-mena-fabry-disease-treatment-market
LATAM Gaucher Disease Treatment Market
https://www.polarismarketresearch.com/industry-analysis/latin-america-gaucher-disease-treatment-market
Digital Health For Obesity Market
https://www.polarismarketresearch.com/industry-analysis/digital-health-for-obesity-market
Understanding Crucial Role of Antimicrobial Additives in Enhancing Hygiene
https://www.polarismarketresearch.com/blog/understanding-crucial-role-of-antimicrobial-additives-in-enhancing-hygiene

Contact:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.